An update on newer monoclonal antibodies in lymphoma therapy

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
An update on newer monoclonal antibodies in lymphoma therapy ; volume:02 ; number:01 ; year:2016 ; pages:003-007
Asian Journal of Oncology ; 02, Heft 01 (2016), 003-007

Beteiligte Personen und Organisationen
Kadavakolan, Subhashini Archana
Puri, Sonam
Sahay, Sandeep
Joshi, Jitesh

DOI
10.4103/2454-6798.180581
URN
urn:nbn:de:101:1-2019070611392591350247
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:51 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Kadavakolan, Subhashini Archana
  • Puri, Sonam
  • Sahay, Sandeep
  • Joshi, Jitesh

Ähnliche Objekte (12)

Monoclonal antibodies for migraine: an update

Monoclonal antibodies for migraine: an update

Novel CD20 monoclonal antibodies for lymphoma therapy

Novel CD20 monoclonal antibodies for lymphoma therapy

Monoclonal antibodies

Monoclonal antibodies

Monoclonal antibodies in transplantation

Aufsatzsammlung

Monoclonal antibodies in transplantation

Glycoengineering of Monoclonal Antibodies

Hochschulschrift

Glycoengineering of Monoclonal Antibodies

Clinical relevance of new monoclonal antibodies

Konferenzschrift | Kongress

Clinical relevance of new monoclonal antibodies

Establishment of anti-mesothelioma monoclonal antibodies

Establishment of anti-mesothelioma monoclonal antibodies

Mechanically interlocked functionalization of monoclonal antibodies

Mechanically interlocked functionalization of monoclonal antibodies

Enzymatization of mouse monoclonal antibodies to the corresponding catalytic antibodies

Enzymatization of mouse monoclonal antibodies to the corresponding catalytic antibodies

ASCO update on lymphoma

ASCO update on lymphoma

Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cells

Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cells

Subcutaneous Administration of Monoclonal Antibodies in Oncology

Subcutaneous Administration of Monoclonal Antibodies in Oncology

Verbundene Objekte